Background: This systemic analysis was conducted to evaluate the efficacy and safety of
pemetrexed based chemotherapy in treating patients with metastatic gastric cancer (MGC) …

Objective: To further observe the efficacy and safety of pemetrexed, combined with
Irinotecan or oxaliplatin or cisplatin in treating patients with advanced gastric cancer as …

Purpose: This study was to determine the efficacy and safety of pemetrexed based
chemotherapy in treating patients with metastatic gastric cancer who failed to respond to first …

Purpose: This study was conducted to observe the efficacy and safety of pemetrexed based
chemotherapy in treating patients with locally advanced or metastatic cancers as first-line …

Purpose: This systematic analysis was conducted to evaluate the efficacy and safety of
pemetrexed based salvage chemotherapy for treatment of patients with metastatic colorectal …

Background: This systemic analysis was conducted to evaluate the efficacy and safety of
pemetrexed basedchemotherapy in treating patients with metastatic breast cancer as first or …

Purpose: To investigate the safety and efficacy of pemetrexed combined with chemotherapy
as second or third line in patients with stage IV colorectal cancer (CRC). Patients and …

Background: Phase II and III trials of docetaxel, cisplatin and fluorouracil (DCF) have shown
superior efficacy versus cisplatin and fluorouracil alone but with high rates of hematologic …

Background: Docetaxel and cisplatin in combination with fluorouracil (DCF) regimen is
accepted to be one of the standard regimens in the treatment of advanced gastric cancer …

Methods: This randomized, single-center clinical trial was performed on 40 patients with
advanced gastric cancer. The first group received the m-DCF regimen as follows: docetaxel …